Instil Bio Q2 2024 GAAP EPS $(2.29) Beats $(2.85) Estimate
Benzinga Newsdesk 1 year ago
EarningsEarnings BeatsNews
Instil Bio (NASDAQ:TIL) reported quarterly losses of $(2.29) per share which beat the analyst consensus estimate of $(2.85) by 19.65 percent.
Instil Bio (NASDAQ:TIL) reported quarterly losses of $(2.29) per share which beat the analyst consensus estimate of $(2.85) by 19.65 percent.